Oramed posts investor presentation; no new material financial or operational data disclosed

ORAMED PHARMACEUTICALS INC.

Filed an investor presentation dated December 12, 2022 on its website.
Presentation titled 'Addressing the Multibillion-Dollar Injectable Drug Markets with Oral Formulations' provides a general overview.
No specific financial updates, guidance changes, or pipeline milestones were included in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.